Le Lézard
Classified in: Health
Subjects: RCL, CFG

Advisory - One lot of Linessa 21 birth control pills recalled due to missing and mispackaged pills


OTTAWA, ON, June 19, 2021 /CNW/ -

Summary

Issue

Aspen Pharmacare Canada Inc. is recalling one lot (lot 200049, expiry 03/2023) of Linessa 21, a prescription birth control pill, due to missing and mispackaged pills. Some blister packs may be missing pills, may contain more than one tablet in a blister pocket, and may contain pills in the wrong order.

Linessa 21 packages contain 21 coloured pills: 7 light yellow, 7 orange and 7 red, with a different amount of hormone in each colour of pill. The pills are taken daily for three weeks, followed by one week of not taking pills (unless otherwise directed by the prescriber). Taking the pills in the proper order, according to the instructions that accompany the product, is important for preventing pregnancy. Missing a pill, taking a pill out of the proper order, or taking two pills at the same time could lead to undesired pregnancy and other side effects, including spotting and irregular bleeding. It is important to get a replacement package as soon as possible to avoid missing any pills or taking a pill in the wrong order.

Health Canada will update the table below and inform Canadians if additional recalls are necessary.

Affected products

Product

DIN

Lot

Expiry

Linessa 21

02272903

200049

03/2023

Linessa 28 is not currently affected by this issue.

What you should do

        1. Take the next light yellow, orange or red pill in the order that you are due to take, following the proper order of the pills (refer to image B below), and contact your pharmacist for a replacement as soon as possible. Do not miss a pill, take one out of the proper order, or take two pills at the same time.
        2. If you have already missed a pill, have no more pills of the proper colour, or if you are unsure which one to take, use a non-hormonal effective method of birth control (such as condoms) and contact your pharmacist as soon as possible.

Additional information for health professionals:

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 05:15
The "Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The technology is moving faster than the market. Find the...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 05:00
Medical equipment manufacturing company Aohua Endoscopy clinched the Endoscopy Product Innovation Award at the recently held Healthcare Asia Medtech Awards 2024 for its development of the Aohua 4K AQ-300 video endoscopy system, which offers an...

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...



News published on and distributed by: